Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06833437 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

68Ga-Pentixafor PET/CT Versus Adrenal Vein Sampling in Diagnosing Unilateral Subtype of Primary Aldosteronism Concurrent With Autonomous Cortisol Secretion (PREDICT)

StatusRecruiting
PhaseNot applicable
SponsorQifu Li
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv4
  2. Secondary endpoints: 4 to 5v3
  3. Eligibility criteria expanded, about 2 words
    • Study title shortened, about 4 words
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Qifu Li
6 trials monitored
See all monitored trials
To validate the accuracy of 68Ga-Pentixafor PET/CT and adrenal venous sampling (AVS) in subtype diagnosis of PA/ACS patients with adrenal nodules, based on biochemical and clinical remission outcomes, and to determine whether the diagnostic accuracy of 68Ga-Pentixafor PET/CT is non-inferior to AVS.
Trial Details
NCT Number NCT06833437
Lead Sponsor Qifu Li
Collaborators: The Affiliated Hospital Of Southwest Medical University, Changzhi Medical College, First Affiliated Hospital of Kunming Medical University
Conditions
(from sponsor)		 Primary Aldosteronism, Autonomous Cortisol Secretion
Related terms Hyperaldosteronism
Enrollment 178 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov